Since the D'Amico risk classification remains as the main clinical assessment used to guide treatment decisions, there are many published studies in the literature investigating the relationship between D'Amico risk groups and the68Ga-PSMA PET/CT parameters of PCa patients. Here, FOLH1 is linked to posterior cortical atrophy.